post-guid miss
net dbt
rome wasnt built day either
long-await guidanc event turn disappoint due larg part
variou busi headwind end greater consensu expect
headwind mix known rebat guarante reimburs pressur
gener calendar well somewhat unexpect today increment invest
busi long-term care challeng sheer magnitud much
overcom match consensu expect report clear
disappoint creat greater onu execut realiti
alway go transit year term ramp aetna busi
well invest futur new see number invest
increment spend prudent toward creat broader healthcar servic
compani greater total touchpoint across valu chain even today stock
pain frustrat reduc price object po
repres ep formerli roughli ep think use
year prudent accur reflect new run-rat ep
reiter buy rate still believ opportun set front
post-merg although understand bump could remain place
grow pain newco
reduc estim account higher invest
reduc ep ep
driven primarili increment invest across busi well
increas pressur variou move headwind also remov
aetna pdp busi model remind rel synergi
upsid time everi increment synergi yield ep
upcom event catalyst
guidanc complet expect manag activ engag
invest commun includ confer visit highly-
anticip new compani analyst day june nyc
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one largest healthcar compani
unit state provid retail mail
specialti pharmaci dispens servic
pharmaci benefit upon complet
acquisit aetna would becom one
vertic integr publicli trade
healthcar compani base
buy rate driven transform
vertic integr aetna assum deal
close stabl free cash flow appeal
valuat think compani deal aetna
provid ampl short-term long-term synergi
opportun provid clear way extract
valu retail franchis stabl
free cash flow three busi
allow compani gener outsiz
return equiti next year
think transitori natur headwind
biggest issu earn guidanc sheer magnitud headwind
compani face perman other improv
even complet go away latter half beyond base compani
commentari estim identifi almost increment
headwind weigh busi current estim
annual invest tax save start-up cost like gone
base half rebat guarante also like roll given re-
contract alon could serv roughli tailwind estim
alon could worth growth opportun headwind
moder serv addit compon toward rebuild growth
exhibit numer headwind abate/roll-off start late
million
compani file bofa merril lynch global research
note manag provid commentari estim use base assumpt
expect year transit compani integr aetna shift
focu consum
headwind
signific on-going pharmaci reimburs pressur
lack offset
declin benefit new gener slower brand inflat
specif challeng long-term care
guarante net cost model client receiv rebat
grow membership medicar advantag other
role partnership drive innov
establish optim structur health servic offer
record impair long-term care busi
adjust ebit exclud amort intang
full year ep
adjust oper incom
adjust ebit guidanc retail/ltc pharmaci
servic hcb
silverscript pdp move healthcar benefit segment
consolid aetna pbm drive synergi
share repurchas increas dividend debt fall certain level
expect leverag moder improv pay debt line
move pbm in-hous
healthcar benefit earn expect grow modestli
assum season year mimic result
thought headwind
mani headwind transitori spend increas
tax reform
addit opportun manag cost base core mitig
issu move forward
will quantifi drag bucket headwind
tax reform invest creat half drag retail
remaind lack gener
pbm side impact cumul natur rebat
pretti signific driver
peak
client
potenti client given inform
rebat guarante break-open gener much better item get
dollar amount gener launch
less valu break-open gener time launch
single-sourc gener launch
look see improv
rebat retent today
percentag point rang
hcb oper incom grow moder investor may
expect number higher driver
expect growth
make signific invest impact
industri growth
hh rebat rule assum rule final effect fulli off-set
premium increas impact pdp implic
ye would underwrit higher premium
biggest chang sinc gave accret guidanc given consensu
ep
primari issu pharmaci reimburs secular headwind
term accret number given deal close
difficult compar
aetna perform better expect
support transform engag member chronic care
digit improv digit mobil experi
aetna benefit basi would aetna grown exclud segment
shift magnitud loss
without shift expect see modest growth driven
commerci govern membership growth
start peak residu
price object base ep estim multipl
five-year averag absolut basi toward lower end
histor rang also repres bigger discount vs
last five year discount reflect margin pressur across core pharmaci
servic retail pharmaci segment uncertainti around drug price
downsid risk po risk amazon anoth disrupt forc enter
suppli chain failur gener gener expect synergi aetna
transact regulatori issu relat post-clos activ grow
competit risk pharmaci benefit market includ competit price around
rebat slow prescription/insur trend upsid risk po
potenti prescript volum pickup faster stronger expect synergi
aetna improv front-end perform
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
